Form CORRESP - Correspondence:
SEC Accession No. 0001493152-23-044606
Filing Date
2023-12-12
Accepted
2023-12-12 17:25:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 48034
2 corresp_002.jpg GRAPHIC 7155
  Complete submission text file 0001493152-23-044606.txt   59105
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)